Scientists unveil synthetic cells to power low-carbon factories - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Scientists unveil synthetic cells to power low-carbon factories

Invention known as SpudCell is part of effort to use micro-scale bioengineering in manufacture of everyday items
00:00

{"text":[[{"start":7.7,"text":"Scientists have unveiled synthetic cells aimed at revolutionising industrial production by serving as tiny biological factories to make environmentally friendly materials for goods from drugs to plastics."}],[{"start":19.9,"text":"The new invention known as SpudCell will be made available to researchers around the world, as part of an expanding effort to put micro-scale bioengineering at the heart of lower-carbon manufacturing for everyday items.SpudCell is the first synthetic system to achieve a complete cell cycle of feeding, growth and reproduction, according to a paper released on Wednesday but not yet peer-reviewed. It is built from the bottom up using known non-living chemical components, as opposed to previous methods based on pared-down living cells and their naturally occurring parts."}],[{"start":54.4,"text":"The discovery highlights how progress in synthetic biology is opening dramatic new possibilities for turning cells from existing life forms and human-made variations on them into miniature workshops. The advances have intensified debate over how the powerful technologies should be owned and regulated, particularly if it one day becomes possible to make living organisms in laboratories.Bioengineered microbes are already used as miniature factories to make products such as insulin and biodegradable plastics. The consultancy McKinsey estimated in 2023 that 400 use cases of bioengineering more widely, almost all of them scientifically feasible, could have an annual economic impact of $2tn to $4tn from 2030 to 2040."}],[{"start":103.05,"text":"“We need to be able to manufacture things in a way that doesn’t harm the planet and in a way that’s actually renewable,” said Kate Adamala, leader of the SpudCell project and a University of Minnesota scientist. “We have enough atoms on this planet. We just need to move those atoms in a way that’s more sustainable — and also politically more decentralised.”"}],[{"start":122.55,"text":"“This is the first time the full cycle of a living cell has been run in a system that was built, not born — assembled from scratch rather than scaled down from something already alive,” the researchers said, noting that SpudCells could in principle be custom-built to make a variety of products. “This work opens up entire fields, and could ultimately underlie new therapeutics, materials, foods and approaches to carbon removal in the long-term future.”"}],[{"start":147.5,"text":"SpudCell still had several areas of scope for improvement, the scientists said. These include reducing its dependence on external food sources, increasing the sophistication of its reproduction mechanisms and building its own capacity to manufacture proteins."}],[{"start":162.45,"text":"The patent to SpudCell is owned by the University of Minnesota and exclusively licensed to Biotic, a US-based non-profit organisation with the stated aim of promoting the collaborative building of vital synthetic cell infrastructure. The researchers compare Biotic’s ambition to how the Human Genome Project was aimed at ensuring a “critical piece of human heritage” should “become a common scientific tool”."}],[{"start":187.64999999999998,"text":"The SpudCell work “opens the door to being able to have a simple system that can be asked to produce specific things at scale”, said Roseanna Zia, a University of Missouri engineering professor and expert on the modelling of biological cells.  "}],[{"start":202.89999999999998,"text":"Efforts by Biotic and other researchers could help ensure synthetic cell technology was not “locked up in patents that would allow only big companies to take advantage”, said John Glass, leader of the synthetic biology group at the J Craig Venter Institute."}],[{"start":218.74999999999997,"text":"“I think synthetic biology and synthetic cells can go a long way towards solving many of the world’s economic, medical, environmental and industrial problems,” Glass said. “Open-source or some version of open-source technology is the best way to make this happen.”"}],[{"start":235.84999999999997,"text":"Advances in bioengineering have stoked concerns about the potential for technologies to cause harm to living organisms, either through accidental leaks or deliberate targeting.  "}],[{"start":245.69999999999996,"text":"SpudCell cannot survive outside controlled laboratory conditions and so presents only a remote risk of use as a bioweapon, its creators argue."}],[{"start":255.24999999999997,"text":"Good governance of the development of synthetic cell technology was vital given the dangers posed by hackers and other bad actors, said Juan Pérez-Mercader, a senior research fellow at Harvard University’s Origins of Life Initiative."}],[{"start":268.79999999999995,"text":"“Guards must be placed lest we affect in irreversible ways the evolution of natural life,” Pérez-Mercader said. “Biotic could be a great first step in the direction of fostering the research and promoting necessary engineering standards and ethics.” "}],[{"start":291.29999999999995,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1783086940_7915.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

FT民调:美国选民担忧特朗普执政期间的腐败问题

随着中期选举临近,美国人将腐败与生活负担危机联系起来。

丰田在人形机器人竞赛中迎战特斯拉和中国

丰田正将二十年来在机器人领域的研发成果商业化,进军智能机器人市场,并与特斯拉、小鹏和现代展开竞争。

空客将与贝宜系统就参与全球作战空中计划战机项目展开谈判

与法国、西班牙的竞争性未来空战系统(FCAS)合作项目破裂后,德国正考虑加入英国、意大利和日本的项目。

一周展望:美联储会释放加息信号吗?

投资者还将关注欧洲央行是否会对法国的局势采取行动,以及日本央行是否会明确支持市场对利率路径的预期。
1小时前

奥迪将在美国建厂,投资40亿美元以应对关税

这项举措是在特朗普于佐治亚州举行的集会上宣布的,正值这家汽车制造商及其母公司大众寻求减轻总统加征关税的压力。

摩科瑞因霍尔木兹海峡危机期间的运价争议,将“航运界道琼斯”告上法庭

此案将检验波罗的海交易所在战事期间继续发布经霍尔木兹海峡运输石油的运价估算,是否妥当。
设置字号×
最小
较小
默认
较大
最大
分享×